Sustainability & Climate

For the seventh year, General Mills is one of America's most responsible companies. We explore the data, public trust, and strategy behind this major ESG achievement.

Radiation tech giant Mirion appoints three new executives, signaling a major strategic push into next-gen nuclear, advanced cancer care, and AI.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.

Katherine Stueland’s honor underscores a major shift in healthcare, as genomic screening and AI promise to end the diagnostic odyssey for rare diseases.

UCLA's Dr. Donald Kohn joins the Jeffrey Modell Foundation to discuss revolutionary gene therapies offering new hope for Primary Immunodeficiency patients.

BrightNight's massive solar and battery project in Yuma County promises reliable power, hundreds of jobs, and millions for Arizona's schools.

From Millennial micro-cruises to Boomer bucket lists, a new report reveals the deep generational divides reshaping the future of travel and tourism.

Rapid7's 2026 awards reveal a shift in cybersecurity, where partners are no longer just resellers but crucial allies in the global, AI-driven fight.

A new partnership with Uniphar will use managed access programs to provide the lymphoma therapy LYMPHIR to European patients with limited treatment options.

A strategic franchise acquisition in Fairfield County aims to serve Connecticut's rapidly aging population, ensuring continuity of care for local seniors.

Aveanna Healthcare's Heartways program earns a top national certification, signaling a major shift in managing America's costliest disease from home.

A new on-demand, automated transit system breaks ground near ATL. Can these futuristic pods solve traffic woes and fuel economic growth for South Metro?

With a new OTCQB listing, Pecoy Copper aims to unlock U.S. capital for its massive Peruvian project amid a looming global copper shortage.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

Amid a surging aerospace market, StandardAero's upcoming earnings report is highly anticipated after a year of record growth and strategic expansion.

Health Canada grants conditional approval to BioMarin's VOXZOGO, the first drug in the country to target the genetic cause of achondroplasia.

NervGen Pharma to unveil data showing its drug NVG-291 provides lasting functional gains for chronic spinal cord injury, a major step forward.

Terex declared a steady dividend, but the real story is its surging stock and a bold forecast, revealing deep confidence in its strategic direction.

New research proves pocket-sized, AI-powered ultrasound is a game-changer for urgent care, tackling staff shortages and improving patient outcomes.

With key leadership promotions, AscellaHealth aims to streamline the complex path from drug discovery to patient delivery for life sciences companies worldwide.